Pro-apoptotic signaling in neuronal cells following iron and amyloid beta peptide neurotoxicity

被引:45
作者
Kuperstein, F [1 ]
Yavin, E [1 ]
机构
[1] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel
关键词
Alzheimer's disease; iron; neuronal cell death; oxidative stress; PKC; signal transduction;
D O I
10.1046/j.1471-4159.2003.01831.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In a previous report, we characterized several oxidative stress parameters during the course of amyloid beta (Abeta) peptide/Fe2+ -induced apoptotic death in neuronal cells. In extending these findings, we now report a marked decrease in protein kinase C (PKC) isoforms, reduced Akt serine/threonine kinase activity, Bcl 2-associated death promoter (BAD) phosphorylation and enhanced p38 mitogen-activated protein kinase (MAPK) and caspase-9 and -3 activation, 12 h after addition of both 5 mum Abeta and 5 mum Fe2+ . These activities reminiscent for a pro-apoptotic cellular course were blocked in the presence of the iron chelator deferroxamine. Abeta alone, increased PKC isoform levels between three- and four-fold after 12 h, enhanced Akt activity approximately eight-fold and Ser136 BAD phosphorylation two-fold, suggesting that by itself is not toxic. Fe2+ alone transiently enhanced p38 MAPK and caspase-9 and -3 enzymes indicative for cell damage, but was not sufficient to cause cell death as previously indicated. GF, a PKC inhibitor or wortmannin, a blocker of the Akt pathway enhanced Abeta/Fe2+ -induced toxicity, while SB, a p38 MAPK inhibitor, prevented cell damage and apoptosis. These findings further support the hypothesis that metal ion chelation and inhibitors of pro-apoptotic kinase cascades may be beneficial for Alzheimer's disease therapy.
引用
收藏
页码:114 / 125
页数:12
相关论文
共 82 条
[1]  
ALCANTARA O, 1994, BLOOD, V84, P3510
[2]   Cross-talk unfolded:: MARCKS proteins [J].
Arbuzova, A ;
Schmitz, AAP ;
Vergères, G .
BIOCHEMICAL JOURNAL, 2002, 362 :1-12
[3]   Characterization of copper interactions with Alzheimer amyloid β peptides:: Identification of an attomolar-affinity copper binding site on amyloid β1-42 [J].
Atwood, CS ;
Scarpa, RC ;
Huang, XD ;
Moir, RD ;
Jones, WD ;
Fairlie, DP ;
Tanzi, RE ;
Bush, AI .
JOURNAL OF NEUROCHEMISTRY, 2000, 75 (03) :1219-1233
[4]  
Atwood CS, 1999, MET IONS BIOL SYST, V36, P309
[5]   SOLUTION CONFORMATIONS AND AGGREGATIONAL PROPERTIES OF SYNTHETIC AMYLOID BETA-PEPTIDES OF ALZHEIMERS-DISEASE - ANALYSIS OF CIRCULAR-DICHROISM SPECTRA [J].
BARROW, CJ ;
YASUDA, A ;
KENNY, PTM ;
ZAGORSKI, MG .
JOURNAL OF MOLECULAR BIOLOGY, 1992, 225 (04) :1075-1093
[6]   Apoptosis and Alzheimer's disease [J].
Behl, C .
JOURNAL OF NEURAL TRANSMISSION, 2000, 107 (11) :1325-1344
[7]   Amyloid β-protein toxicity and oxidative stress in Alzheimer's disease [J].
Behl, C .
CELL AND TISSUE RESEARCH, 1997, 290 (03) :471-480
[8]   New perspectives on iron: An introduction [J].
Boldt, DH .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1999, 318 (04) :207-212
[9]   Frequency of stages of Alzheimer-related lesions in different age categories [J].
Braak, H ;
Braak, E .
NEUROBIOLOGY OF AGING, 1997, 18 (04) :351-357
[10]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P238